Navigation Links
Advancing Mesothelioma Research
Date:2/24/2010

Mesothelioma Applied Research Foundation funds eight new research projects to advance critically-needed mesothelioma treatments.

(PRWEB) February 24, 2010 -- The Mesothelioma Applied Research Foundation (Meso Foundation) announced today awards of an additional $800,000 to researchers, at top national and international medical science centers, devoted to finding a cure for mesothelioma. This brings to almost $7 million the funds the Foundation has awarded to develop better treatment options for mesothelioma patients. To spur the research critically needed to develop treatments for this long-overlooked, asbestos-related cancer, the Meso Foundation annually funds the top research projects from around the world.

“The grants that were selected for funding this year, have the potential to accelerate development of novel therapies that will have a significant impact on how we treat patients with mesothelioma,” says Raffit Hassan, MD, Senior Investigator at the National Cancer Institute and Meso Foundation Science Advisory Board Chairman.

This round, the Meso Foundation received 56 grant applications. Its scientific peer reviewers selected the top eight based on their innovation, research design, and promise. These include studies of a targeted vaccine anticipated to yield effective treatment without the side-effects currently associated with traditional mesothelioma treatment; a novel study of the role of hormones in malignant mesothelioma; several studies looking at improving the specificity and effectiveness in mesothelioma of drugs already available to cancer patients, while reducing their side effects; and a study focused specifically on peritoneal mesothelioma, aimed at targeting residual tumor cells after surgical debulking as well as enabling earlier detection. The full list of projects can be seen in the Mesothelioma Research Grant Awards section of CureMeso.org.

“We are thrilled that our mesothelioma research funding continues to foster such strong interest among brilliant medical scientists and we have high expectations for these projects. As the national nonprofit advocating for mesothelioma patients today, and for all those who will be diagnosed in the future, we will continue raising funds for life-saving research and we won’t stop until there is a cure,” says Chris Hahn, Executive Director for the Mesothelioma Applied Research Foundation.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen or heart caused by asbestos. Medical experts consider it one of the most aggressive of all cancers. For decades it was regarded as untreatable, deadly and hopeless; and so, in a sad, self-fulfilling prophecy, the need for research to develop effective treatments was mostly ignored. For the Mesothelioma Applied Research Foundation and today’s patients, their families, and the millions of Americans who in the last five decades have been exposed to asbestos and are at risk for the cancer, this is unacceptable. The Foundation believes in a cure for this tragic disease, and is committed to funding the research critically-needed to understand and improve treatment of the disease.

In addition, the Mesothelioma Applied Research Foundation provides patients and families with the most up-to-date information on mesothelioma treatments, clinical trials and medical referrals. The Foundation hosts the annual International Symposium on Malignant Mesothelioma, which unites doctors, researchers, patients and families, legal advocates, union representatives and other concerned individuals to share information and advance meso research. The Foundation also leads the effort in Washington, D.C. to gain federal investment in mesothelioma research funding and to ban the further use of asbestos. For more information visit the Mesothelioma Applied Research Foundation’s website at http://www.curemeso.org.

###

Read the full story at http://www.prweb.com/releases/mesothelioma-research/mesothelioma-treatment/prweb3644754.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Which Health Care Organizations Are Advancing Consumer Protection and Empowerment?
2. Top Medical Organizations Advancing Women's Health on Medpedia
3. Michigan Blues Lead the Way in Hiring, Advancing People With Disabilities
4. APHA Applauds Senate for Advancing Health Reform Bill
5. The ZigBee Alliance and the American Telemedicine Association to Collaborate on Advancing Use of Telehealth Solutions
6. American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation
7. Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education
8. Abbott Receives CE Mark for Companys Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
9. Tim McGraw and Faith Hill Join Senior Military for Country United: Advancing Medicine From the Frontlines to the Homefront
10. MU researchers offer insights for advancing health communication through digital media
11. American Psychiatric Foundation Names 2009 Recipients of Awards for Advancing Minority Mental Health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Advancing Mesothelioma Research
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: